Changes in serum metabolites with the stage of chronic kidney disease: Comparison of diabetes and non-diabetes

Metabolomics is useful clinically for providing a metabolic signature that is associated with the CKD phenotype and diabetes more seriously affects patients with early stage CKD compared to those with advanced CKD.